OptimizeRx Corp. (NASDAQ: OPRX), a provider of healthcare technology solutions for life sciences companies, announced that it has entered into a $35 million senior secured credit facility with Fifth Third Bank. The facility consists of a $25 million term loan and a $10 million revolving credit facility that was undrawn at closing. Roth Capital Partners served as financial advisor on the transaction.
The new credit facility provides OptimizeRx with increased financial flexibility to support its growth initiatives, including potential acquisitions, investments in its technology platform, and working capital needs. The company’s platform combines innovative AI-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement between life science brands and healthcare providers and patients.
This financing is significant for OptimizeRx as it strengthens its balance sheet and positions the company to capitalize on opportunities in the evolving healthcare technology landscape. The undrawn revolving credit facility offers additional liquidity for future needs. The company’s focus on privacy-safe, patient-centric technology aligns with industry trends toward personalized medicine and value-based care.
For more details, the full announcement can be accessed at https://ibn.fm/G0Fj3.
